Straumann: the investment case is still attractive

27th February 2020
-News, IAM

Olivier Aeschlimann, Senior Financial Analyst

The dental implant manufacturer once again saw double-digit growth in the past financial year. Organically, i.e. without acquisitions or currency effects, growth was around 17%. Since 2016, the Basel headquartered company has grown organically in double digits every quarter. Looking ahead, the company is a bit more cautious, but it still wants gain further market share in 2020. To achieve this, a new brand with the name Nuvo will be launched to move deeper in the budget segment. The objective is to increase the group’s turnover in lower income markets. Regarding the impact of the Coronavirus, the company expects sales to be around CHF 30 million lower than planned in the period.

Loading...